• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤在X线片上的矿化变化与采用骨减法的化疗反应具有中度相关性。

Osteosarcoma mineralization changes on radiographs have moderate correlation to chemotherapy response using bone subtraction methodology.

作者信息

Henderson Eric R, Xu Xiaochun, Pogue Brian W, Samkoe Kimberley S, Anderson Megan E

机构信息

Sarcoma & Connective Tissue Oncology Program & Department of Orthopaedic Surgery, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

出版信息

Ann Jt. 2020 Oct;5. doi: 10.21037/aoj-20-70. Epub 2020 Oct 15.

DOI:10.21037/aoj-20-70
PMID:36051544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9430774/
Abstract

BACKGROUND

Survival following a diagnosis of osteosarcoma is correlated strongly with response to chemotherapy. Mineralization changes seen on radiographs have been hypothesized to correlate with chemotherapy response, however, this has never been analyzed using modern techniques.

METHODS

Retrospective review of radiographs obtained before and after neoadjuvant chemotherapy was performed for 31 patients with high-grade, conventional osteosarcoma. Pre-chemotherapy (PreC) images and post-chemotherapy (PostC) images were co-registered. Tumor luminance measurements were normalized based on the non-tumor bone and then the relative change in tumor mineralization were measured.

RESULTS

Mean luminance values for pre-chemotherapy non-tumor-affected bone and tumor were 0.63±0.12 and 0.65±0.12, respectively. Mean values for PostC non-tumor-affected bone were 0.59±0.14 and 0.64±0.10, respectively. Once normalized, osteosarcoma mineralization change showed a statistically significant moderate correlation-Pearson correlation coefficient (ρ) of 0.36 (P=0.038)-with the tumor necrosis value.

CONCLUSIONS

Moderate, positive correlation was found between osteosarcoma mineralization change during chemotherapy and chemotherapy response. Further work is required to determine if these findings are prognostic by identifying best practice for image analysis and repeating this work with prospectively acquired digital radiographs using uniform technique and phantom normalization.

摘要

背景

骨肉瘤诊断后的生存率与化疗反应密切相关。X线片上观察到的矿化变化被认为与化疗反应相关,然而,从未使用现代技术对此进行分析。

方法

对31例高级别、传统型骨肉瘤患者新辅助化疗前后获得的X线片进行回顾性研究。将化疗前(PreC)图像和化疗后(PostC)图像进行配准。基于非肿瘤骨对肿瘤亮度测量值进行归一化,然后测量肿瘤矿化的相对变化。

结果

化疗前非肿瘤受累骨和肿瘤的平均亮度值分别为0.63±0.12和0.65±0.12。化疗后非肿瘤受累骨的平均值分别为0.59±0.14和0.64±0.10。归一化后,骨肉瘤矿化变化与肿瘤坏死值呈统计学显著的中度相关性——Pearson相关系数(ρ)为0.36(P = 0.038)。

结论

化疗期间骨肉瘤矿化变化与化疗反应之间存在中度正相关。需要进一步开展工作,通过确定图像分析的最佳实践,并使用统一技术和体模归一化对前瞻性获取的数字X线片重复此项工作,来确定这些发现是否具有预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc3/9430774/a1b6ae0ef0c3/nihms-1813817-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc3/9430774/6576f26d5083/nihms-1813817-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc3/9430774/a1b6ae0ef0c3/nihms-1813817-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc3/9430774/6576f26d5083/nihms-1813817-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc3/9430774/a1b6ae0ef0c3/nihms-1813817-f0002.jpg

相似文献

1
Osteosarcoma mineralization changes on radiographs have moderate correlation to chemotherapy response using bone subtraction methodology.骨肉瘤在X线片上的矿化变化与采用骨减法的化疗反应具有中度相关性。
Ann Jt. 2020 Oct;5. doi: 10.21037/aoj-20-70. Epub 2020 Oct 15.
2
Quantification of Osteosarcoma Mineralization on Plain Radiographs - Novel Software Applications to Assess Response to Chemotherapy.平片上骨肉瘤矿化的定量分析——评估化疗反应的新型软件应用
Proc SPIE Int Soc Opt Eng. 2020 Feb;11224. doi: 10.1117/12.2546954. Epub 2020 Feb 25.
3
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.18F-FDG PET/CT 与弥散加权磁共振成像联合预测骨肉瘤新辅助化疗的组织学反应:初步结果。
J Nucl Med. 2013 Jul;54(7):1053-9. doi: 10.2967/jnumed.112.115964. Epub 2013 May 13.
4
Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.应用扩散加权成像评估长骨骨肉瘤新辅助化疗的疗效:初步活体研究。
PLoS One. 2013 Aug 26;8(8):e72679. doi: 10.1371/journal.pone.0072679. eCollection 2013.
5
Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.骨肉瘤化疗后的局部宿主反应与X线片、CT、肿瘤坏死及患者生存率的关系。
J Cancer Res Clin Oncol. 1998;124(10):575-80. doi: 10.1007/s004320050217.
6
T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.T1 映射作为骨肉瘤患者化疗反应评估的替代标志物。
Eur J Radiol. 2022 Mar;148:110170. doi: 10.1016/j.ejrad.2022.110170. Epub 2022 Jan 20.
7
Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.组织病理学与多模态磁共振成像在儿童骨肉瘤中的相关性:预测肿瘤对化疗的反应。
PLoS One. 2022 Feb 14;17(2):e0259564. doi: 10.1371/journal.pone.0259564. eCollection 2022.
8
Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.新辅助化疗后骨肉瘤的表观扩散系数与组织病理学亚型之间的相关性
Acta Radiol. 2017 Aug;58(8):971-976. doi: 10.1177/0284185116678276. Epub 2016 Nov 16.
9
Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.MRI 在骨肉瘤化疗反应评估和预测中的作用:与组织学坏死的相关性。
Pediatr Radiol. 2011 Apr;41(4):441-50. doi: 10.1007/s00247-010-1876-3. Epub 2010 Oct 27.
10
Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.新辅助多药化疗包括大剂量甲氨蝶呤可改变骨肉瘤中 VEGF 的表达:免疫组化分析。
BMC Musculoskelet Disord. 2010 Feb 16;11:34. doi: 10.1186/1471-2474-11-34.

引用本文的文献

1
Quantification of Osteosarcoma Mineralization on Plain Radiographs - Novel Software Applications to Assess Response to Chemotherapy.平片上骨肉瘤矿化的定量分析——评估化疗反应的新型软件应用
Proc SPIE Int Soc Opt Eng. 2020 Feb;11224. doi: 10.1117/12.2546954. Epub 2020 Feb 25.

本文引用的文献

1
A Modified Lodwick-Madewell Grading System for the Evaluation of Lytic Bone Lesions.一种用于评估溶骨性骨病变的改良Lodwick-Madewell分级系统。
AJR Am J Roentgenol. 2016 Jul;207(1):150-6. doi: 10.2214/AJR.15.14368. Epub 2016 Apr 12.
2
Osteosarcoma: A Meta-Analysis and Review of the Literature.骨肉瘤:一项荟萃分析及文献综述
Am J Orthop (Belle Mead NJ). 2015 Dec;44(12):547-53.
3
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.使用序贯¹⁸F-FDG PET/CT和MRI对骨肉瘤新辅助化疗进行早期反应监测
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1553-62. doi: 10.1007/s00259-014-2746-2. Epub 2014 Mar 21.
4
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.18F-FDG PET/CT 与弥散加权磁共振成像联合预测骨肉瘤新辅助化疗的组织学反应:初步结果。
J Nucl Med. 2013 Jul;54(7):1053-9. doi: 10.2967/jnumed.112.115964. Epub 2013 May 13.
5
FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像可预测成人原发性骨肉瘤新辅助治疗后的组织病理学治疗反应。
Sarcoma. 2010;2010:143540. doi: 10.1155/2010/143540. Epub 2010 Apr 18.
6
Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy.儿童和青少年骨肉瘤的影像学评估:诊断、分期及化疗反应评估
Cancer Treat Res. 2009;152:33-62. doi: 10.1007/978-1-4419-0284-9_3.
7
The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.弥散加权成像在监测骨肉瘤化疗反应中的价值:平均表观弥散系数与最小表观弥散系数的比较。
Skeletal Radiol. 2010 Feb;39(2):141-6. doi: 10.1007/s00256-009-0830-7. Epub 2009 Nov 19.
8
Binocular contrast vision at and above threshold.阈值及高于阈值时的双眼对比视觉。
J Vis. 2006 Oct 23;6(11):1224-43. doi: 10.1167/6.11.7.
9
Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.化疗期间采用扩散加权磁共振成像评估肿瘤坏死:骨肉瘤的初步结果
Pediatr Radiol. 2006 Dec;36(12):1306-11. doi: 10.1007/s00247-006-0324-x. Epub 2006 Oct 10.
10
Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.通过扩散加权成像监测原发性骨肿瘤的治疗反应:初步结果。
Eur Radiol. 2006 Dec;16(12):2637-43. doi: 10.1007/s00330-006-0342-y. Epub 2006 Aug 15.